Speaker Evaluation

Question Title

* 1. Please provide FIRST and LAST Name:

Question Title

* 2. Please provide your Email Address:

Question Title

* 3. Medical Specialty* (Please select one. If other, please specify):

Question Title

* 4. Type of Practice:

Question Title

* 5. Practice Location:

SESSION I:   Chair: Akshay Bagai, MD

Question Title

* 6. Speaker: Beth Abramson, MD
Topic: Thresholds instead of targets in lipid lowering and prevention in ASCVD

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 7. Speaker: Anatoly Langer, MD
Topic: Evidence based choices in lipid lowering beyond statin

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 8. Speaker: Shaun Goodman, MD
Topic: Beyond LDL-C lowering: anti-inflammatory therapies for CAD

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 9. Speaker: Kim Connelly, MD
Topic: Type 2 Diabetes Mellitus and ASCVD: SGLT2 inhibitors, GLP-1 receptor agonists, or both?            

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 10. Speaker: Faculty
Topic: Panel Discussion with audience, moderated session, Q&A augmented by use of on-line chat, Q&A or raising of hand

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate
SESSION II:  Chairs: Kaja Konieczny, MD

Question Title

* 11. Speaker: Paul Dorian, MD
Topic: Which AF requires treatment and which treatment?             

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 12. Speaker: Andrew Yan, MD
Topic: What is the role for aspirin in CVD prevention?

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 13. Speaker: Charles de Mestral, MD
Topic: Peripheral artery disease: Underappreciated and undertreated           

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 14. Speaker: Yin Ge, MD
Topic: Diagnosis and management of patients with chest pain

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 15. Speaker: Faculty
Topic: Panel Discussion with audience, moderated session, Q&A augmented by use of on-line chat, Q&A or raising of hand

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate
SESSION III:  Chairs: Geraldine Ong, MD

Question Title

* 16. Speaker: Chi-Ming Chow, MD
Topic: What is the new standard of care in hypertension?              

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 17. Speaker: Susanna Mak, MD
Topic: Evidence-based HFrEF management: I need two hands to count

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 18. Speaker: Gordon Moe, MD
Topic: Evidence-based management of HFpEF: are my hands free?             

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 19. Speaker: Faculty
Topic: Panel Discussion with audience, moderated session, Q&A augmented by use of on-line chat, Q&A or raising of hand

  1 = Strongly Disagree 2 = Disagree 3 = Neutral 4 = Agree 5 = Strongly Agree
Speaker / Presentation was Balanced & Unbiased
Was consistent with stated objectives
Information was presented clearly
Information was relevant to practice
Discussion time was adequate

Question Title

* 20. Comments:

T